+16.6%
EMR vs CVE
+99.6%
-83.0%
-23.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CVE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | -1.3% | +3.0% | +1.7% |
| 7D | -1.5% | +2.5% | -4.0% | -1.4% |
| 30D | -5.6% | +16.7% | -22.4% | -4.6% |
| 3M | +7.9% | +9.3% | -1.3% | +9.4% |
| 6M | +6.0% | +43.6% | -37.6% | +2.4% |
| YTD | +16.4% | +93.6% | -77.1% | +7.2% |
| 1Y | +16.6% | +98.8% | -82.1% | +9.3% |
| All | +16.6% | +99.6% | -83.0% | +9.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CVE.
Daily Out/Under-Performance
Portfolio return minus CVE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling